価格表

在庫・価格 : 2025年10月08日 10時33分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human B7-2/CD86 Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF-141-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥28,000
(未発注)
追加

在庫・価格 : 2025年10月08日 10時33分 現在

Anti-Human B7-2/CD86 Affinity Purified Polyclonal Ab

  • 商品コード:AF-141-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥28,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Schatton T et al. Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res. 2010 Jan;70(2):697-708
Schatton T et al
2010/01/01
Species: Human, Applications: IHC PubMed
2 Sakthivel P et al. The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysm. J. Intern. Med. 2007 Apr;261(4):399-407
Sakthivel P et al
2007/01/01
Species: Human, Applications: ELISA Development PubMed
3 Hock BD et al. Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients. Leukemia 2002 May;16(5):865-73
Hock BD et al
2002/01/01
Species: Human, Applications: ELISA Development PubMed
4 Ai P et al. Tumor microenvironment contributes to Epstein-Barr virus anti-nuclear antigen-1 antibody production in nasopharyngeal carcinoma. Oncol Lett 2017 Aug;14(2):2458-2462
Ai P et al
2017/01/01
Species: Human, Applications: IHC-P PubMed
5 Zrzavy T et al. Loss of homeostatic' microglia and patterns of their activation in active multiple sclerosis. Brain 2017 Jul;140(7):1900-1913
Zrzavy T et al
2017/01/01
Species: Human, Applications: IHC-P PubMed
6 Mansfield AS et al. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod. Pathol. 2011 Apr;24(4):487-94
Mansfield AS et al
2011/01/01
Species: Human, Applications: IHC-P PubMed
  • No.: 1
  • 文献情報:
    Schatton T et al. Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res. 2010 Jan;70(2):697-708
    Schatton T et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sakthivel P et al. The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysm. J. Intern. Med. 2007 Apr;261(4):399-407
    Sakthivel P et al
    2007/01/01
  • 備考:
    Species: Human, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hock BD et al. Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients. Leukemia 2002 May;16(5):865-73
    Hock BD et al
    2002/01/01
  • 備考:
    Species: Human, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ai P et al. Tumor microenvironment contributes to Epstein-Barr virus anti-nuclear antigen-1 antibody production in nasopharyngeal carcinoma. Oncol Lett 2017 Aug;14(2):2458-2462
    Ai P et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Zrzavy T et al. Loss of homeostatic' microglia and patterns of their activation in active multiple sclerosis. Brain 2017 Jul;140(7):1900-1913
    Zrzavy T et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Mansfield AS et al. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod. Pathol. 2011 Apr;24(4):487-94
    Mansfield AS et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed